Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Beclomethasone Dipropionate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 6/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.95 |
| ▸ | USP2 | O75604 | 6/20 | 0.95 |
| ▸ | PGR | P06401 | 5/20 | 0.95 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.95 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.95 |
| ▸ | AR | P10275 | 2/20 | 0.95 |
| ▸ | CNR1 | P21554 | 2/20 | 0.95 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.95 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.95 |
| ▸ | MAPT | P10636 | 3/20 | 0.77 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.77 |
| ▸ | DRD2 | P14416 | 1/20 | 0.77 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.77 |
| ▸ | LMNA | P02545 | 5/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 4/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | MLNR | O43193 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beclomethasone Dipropionate SCHEMBL14782876 | 1.00 | CYP3A4 (0.95) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL74651 | 0.99 | CYP3A4 (0.94) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL3930413 | 0.98 | CYP3A4 (0.91) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL10392062 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL19681908 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL6941956 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL13653326 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL9768491 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL6890 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A | |
| Beclomethasone Dipropionate SCHEMBL2404673 | 0.98 | CYP3A4 (1.00) | CYP3A4USP2NR3C1PGRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 27521 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026099512-A1 | MEDICAMENT DISPENSER DEVICE | PORTAL MEDICAL LIMITED (GB) | 2026-05-15 | — | — | WO | claimed |
| EP-4739294-A1 | AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE FOR THE TREATMENT OF ASTHMA | Norton (Waterford) Limited (IE) | 2026-05-13 | — | — | EP | claimed |
| EP-4739295-A1 | AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE FOR THE TREATMENT OF ASTHMA | Norton (Waterford) Limited (IE) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260115161-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | LAMINAR PHARMACEUTICALS S A (ES) | 2026-04-30 | — | — | US | claimed |
| EP-4733320-A2 | METHODS OF TREATING CROHN'S DISEASE WITH ANTI-IL23 SPECIFIC ANTIBODY | Janssen Biotech, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| EP-4724038-A1 | PRESERVATIVE-FREE COMPOSITIONS COMPRISING A COMPLEX OF A CORTICOSTEROID AND HPBCD FOR THE TREATMENT OR PREVENTION OF AN INFLAMMATORY DISEASE THROUGH NASAL ADMINISTRATION | Aquilon Pharmaceuticals (BE) | 2026-04-15 | — | — | EP | claimed |
| EP-4701663-A1 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS, COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-03-04 | — | — | EP | claimed |
| US-4350690-A | TOPICAL ANTIINFLAMMATORY AGENTS | CRESSINGTON INVESTMENTS LTD. (HK) | 1982-09-21 | — | — | US | claimed |
| US-4347236-A | Process for the preparation of a mixture of an anti-inflammatory steroid and a fluoro-chloro-hydrocarbon to be used as a propellant | ORION-YHTYMA OY (FI) | 1982-08-31 | — | — | US | claimed |
| US-4343798-A | Topical antimicrobial anti-inflammatory compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-08-10 | — | — | US | claimed |
| US-4333927-A | CORTICOSTEROID, PHOSPHATIDE, BUTYLHYDROXYANISOLE AND/OR BUTYLHYDROXYTOLUENE | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-08 | — | — | US | claimed |
| EP-0050981-A2 | Steroid-containing compositions and their topical uses | Kumana, Cyrus Rustam (CA) | 1982-05-05 | — | — | EP | claimed |
| EP-0039369-A1 | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation | SCHERING CORPORATION (US) | 1981-11-11 | — | — | EP | claimed |
| US-4294829-A | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof | TEIJIN LIMITED (JP) | 1981-10-13 | — | — | US | claimed |
| EP-0023359-A2 | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof | TEIJIN LIMITED (JP) | 1981-02-04 | — | — | EP | claimed |
| US-4225597-A | INHALATION THERAPY, STORAGE STABILITY | SCHERING CORPORATION (US) | 1980-09-30 | — | — | US | claimed |
| US-4199578-A | TREATMENT OF ASTHMA OR HAY FEVER | FISONS LIMITED (GB) | 1980-04-22 | — | — | US | claimed |